Justifying lipid-lowering therapy in persons ≥65 years of age
- 15 December 2002
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (12) , 1330-1332
- https://doi.org/10.1016/s0002-9149(02)02872-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- The design of a prospective study of pravastatin in the elderly at risk (PROSPER)The American Journal of Cardiology, 1999
- Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)American Journal of Hypertension, 1996
- CLINICAL GUIDELINE, PART 1: Guidelines for Using Serum Cholesterol, High-Density Lipoprotein Cholesterol, and Triglyceride Levels as Screening Tests for Preventing Coronary Heart Disease in AdultsAnnals of Internal Medicine, 1996
- Cholesterol and heart disease in older persons and women review of an NHLBI workshopAnnals of Epidemiology, 1992
- Longitudinal study of dietary intakes and plasma lipids in healthy elderly men and womenThe American Journal of Clinical Nutrition, 1992
- Leisure Time Exercise and Lipid and Lipoprotein Levels in an Older PopulationJournal of the American Geriatrics Society, 1990